BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 16824616)

  • 1. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.
    Akiskal HS; Akiskal KK; Lancrenon S; Hantouche EG; Fraud JP; Gury C; Allilaire JF
    J Affect Disord; 2006 Dec; 96(3):197-205. PubMed ID: 16824616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating the soft bipolar spectrum in the French National EPIDEP Study: the prominence of BP-II 1/2.
    Akiskal HS; Akiskal KK; Lancrenon S; Hantouche E
    J Affect Disord; 2006 Dec; 96(3):207-13. PubMed ID: 16647762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP].
    Allilaire JF; Hantouche EG; Sechter D; Bourgeois ML; Azorin JM; Lancrenon S; Châtenet-Duchêne L; Akiskal HS
    Encephale; 2001; 27(2):149-58. PubMed ID: 11407267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum.
    Akiskal HS; Benazzi F
    J Affect Disord; 2006 May; 92(1):45-54. PubMed ID: 16488021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study.
    Akiskal HS; Akiskal K; Allilaire JF; Azorin JM; Bourgeois ML; Sechter D; Fraud JP; Chatenêt-Duchêne L; Lancrenon S; Perugi G; Hantouche EG
    J Affect Disord; 2005 Mar; 85(1-2):29-36. PubMed ID: 15780673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    Benazzi F; Akiskal H
    J Affect Disord; 2005 Feb; 84(2-3):197-207. PubMed ID: 15708417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic course in bipolar II outpatients: prevalence and clinical correlates of a cyclic pattern described by Baillarger and Falret in hospitalised patients in 1854.
    Benazzi F; Akiskal HS
    J Affect Disord; 2006 Dec; 96(3):183-7. PubMed ID: 16427131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP).
    Hantouche EG; Akiskal HS; Lancrenon S; Allilaire JF; Sechter D; Azorin JM; Bourgeois M; Fraud JP; Châtenet-Duchêne L
    J Affect Disord; 1998 Sep; 50(2-3):163-73. PubMed ID: 9858076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association].
    Hantouche EG; Kochman F; Demonfaucon C; Barrot I; Millet B; Lancrenon S; Akiskal HS
    Encephale; 2002; 28(1):21-8. PubMed ID: 11963340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The duration of hypomania in bipolar-II disorder in private practice: methodology and validation.
    Benazzi F; Akiskal H
    J Affect Disord; 2006 Dec; 96(3):189-96. PubMed ID: 16427136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?
    Akiskal HS; Benazzi F
    J Affect Disord; 2005 Feb; 84(2-3):209-17. PubMed ID: 15708418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania.
    Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):279-90. PubMed ID: 15708427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history validation of a definition of mixed depression.
    Benazzi F
    Compr Psychiatry; 2005; 46(3):159-66. PubMed ID: 16021584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures.
    Hantouche EG; Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):127-32. PubMed ID: 15708409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS; Benazzi F
    J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed depression: a clinical marker of bipolar-II disorder.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):267-74. PubMed ID: 15694234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melancholic outpatient depression in Bipolar-II vs. unipolar.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):481-5. PubMed ID: 15093955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.